Compounds > bay i 7433
Page last updated: 2024-08-25

bay i 7433 and Melanoma

bay i 7433 has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frye, D; Hersh, EM; Hortobagyi, GN; Papadopoulos, NE; Plager, C; Quesada, J; Reuben, JM; Rios, A; Rosenblum, M1
Hortobagyi, GN; Rosenblum, MG1

Other Studies

2 other study(ies) available for bay i 7433 and Melanoma

ArticleYear
Initial clinical studies with copovithane.
    Journal of biological response modifiers, 1986, Volume: 5, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Carbamates; Cytotoxicity, Immunologic; Drug Evaluation; Drug Tolerance; Female; Humans; Immunity, Cellular; In Vitro Techniques; Lymphocyte Activation; Male; Melanoma; Middle Aged; Neoplasms; Povidone; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory

1986
Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3

    Topics: Antineoplastic Agents; Biopsy; Carbamates; Chromatography, High Pressure Liquid; Drug Evaluation; Humans; Leiomyosarcoma; Melanoma; Neoplasms; Povidone; Sarcoma, Kaposi; Time Factors; Tissue Distribution

1986